LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 29.33 | 771.67 | 2009 | 2939 | 0.6835 | 0.6420 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 29.33 | 771.67 | 2214 | 2939 | 0.7532 | 0.7268 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 31.55 | 771.67 | 2237 | 3196 | 0.6998 | 0.6804 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 31.55 | 771.67 | 2492 | 3196 | 0.7795 | 0.7713 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 33.78 | 771.67 | 2440 | 3499 | 0.6972 | 0.6952 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 33.78 | 771.67 | 2668 | 3499 | 0.7624 | 0.7661 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 36.00 | 771.67 | 2668 | 3884 | 0.6868 | 0.7024 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 36.00 | 771.67 | 2918 | 3884 | 0.7511 | 0.7690 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 38.22 | 771.67 | 2900 | 4299 | 0.6745 | 0.7061 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 38.22 | 771.67 | 3261 | 4299 | 0.7584 | 0.7889 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 40.44 | 771.67 | 3126 | 4738 | 0.6597 | 0.7062 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 40.44 | 771.67 | 3496 | 4738 | 0.7378 | 0.7807 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 42.67 | 771.67 | 3398 | 5155 | 0.6591 | 0.7177 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 42.67 | 771.67 | 3869 | 5155 | 0.7504 | 0.8010 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 44.89 | 771.67 | 3736 | 5541 | 0.6742 | 0.7411 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 44.89 | 771.67 | 4286 | 5541 | 0.7734 | 0.8273 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 47.11 | 771.67 | 4104 | 5941 | 0.6907 | 0.7639 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 47.11 | 771.67 | 4617 | 5941 | 0.7771 | 0.8358 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 49.33 | 771.67 | 4372 | 6392 | 0.6839 | 0.7658 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 49.33 | 771.67 | 4949 | 6392 | 0.7742 | 0.8390 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 51.55 | 771.67 | 4710 | 6829 | 0.6896 | 0.7772 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 51.55 | 771.67 | 5322 | 6829 | 0.7792 | 0.8475 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 53.77 | 771.67 | 5010 | 7256 | 0.6904 | 0.7835 | MN20160304_L01 | I06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 53.77 | 771.67 | 5741 | 7256 | 0.7912 | 0.8602 | MN20160304_L01 | M17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 55.99 | 771.67 | 5346 | 7690 | 0.6952 | 0.7924 | MN20160304_L01 | I06 |